Employer-sponsored health plans are routinely approached by point solution vendors promising to reduce cost, improve quality, and create a better member experience. The range of offerings is broad: digital musculoskeletal programs, diabetes prevention and management, women’s health and family-building, steerage to centers of excellence, specialty-care navigation, and broader navigation platforms that aim to serve as a front door to the healthcare system. Some vendors offer a narrow, condition-focused service while others combine navigation, virtual care, provider contracting, and/or referral management into a more integrated model.

For plan sponsors, the important questions follow:

• Is the solution aligned with members’ needs?
• Does historical data support the investment?
• Does the solution integrate into the overall benefits strategy?
• Does the proposed operating model meet your organization’s needs?
• Are the return on investment (ROI) targets and methodology actuarially sound?
• Is there capacity to support implementation?

It is worth noting that a vendor may perform well and still not be a fit for a particular employer-sponsored plan. Conversely, a solution with a modest potential ROI may still be worthwhile if it addresses an important care gap, improves access to high-quality providers, reduces friction during high-cost, high-stress episodes of care, or improves employee morale. The most effective evaluation process begins with defining the problem the plan is trying to solve and developing the evidence that is needed to justify the decision.

Evaluating a point solution vendor: Define the problem, the population, and the goal

Before evaluating a vendor, plan sponsors should define and understand the underlying issue as best they can. Potential problems that need to be addressed include increasing high-cost claims, members struggling to navigate complex health episodes, access to care for rural members, lower-quality providers being used, and/or gaps in the current carrier or third-party administrator (TPA) model. Defining the problem and understanding the context of the issue matters because different vendor models address different problems on different timelines. If the plan does not identify which problem it is solving at the outset, the evaluation can quickly become a comparison of marketing stories rather than a disciplined strategic approach.

For example:

• A musculoskeletal or chronic-condition solution may target a high-volume population and seek gradual claims improvement through engagement, behavioral change, and better adherence. In that case, the plan may care most about broad engagement, sustained participation, and whether the vendor reaches members who are not already engaged with the carrier's programs.
• Fertility, surgery, cancer, or specialty-care solutions may serve fewer members but still deliver meaningful value. Because episode costs are high, member experience is complex, and clinical decisions carry high stakes, a significant plan-wide ROI in year one may be less important (and in the case of some services, such as fertility support, may not yet be realized). The value may be in whether the program helps a handful of members avoid poor provider selection, unnecessary procedures, or an inefficient and costly care pathway.

Point solutions should not be judged solely on a financial basis. For example, a fertility vendor with only 20 or 30 cases per year may never produce the same aggregate savings headline as a musculoskeletal solution marketed to thousands of eligible members, but it may still be highly valuable if it reduces health risks, improves medication management or the outcomes (fewer attempts or multiple births), or helps members navigate the healthcare system during a financially and emotionally significant episode. Plan sponsors should decide up front whether they are primarily buying broad utilization management, targeted high-cost episode support, an improved member experience, or some combination of the three.

Population fit should also be tested explicitly. A solution may be well regarded in the market and still be misaligned with a given population. Plan sponsors should ask if the conditions the solution supports are prevalent, understand claim volume (particularly for solutions billed on a per-member basis), workforce characteristics, and member engagement profile, and then determine if all support a partnership with a given vendor. For Taft–Hartley plans in particular, the analysis may need to account for collectively bargained eligibility rules, varying work hours, how onerous required member engagement is, and the degree of trust members place in third-party outreach.

Plan sponsors should also consider whether current benefit programs already address part of the need. The plan sponsor should evaluate whether it may be more effective to strengthen an existing vendor relationship or improve current navigation and communications rather than layering in another point solution.

Evaluate the point solutions economics with as much rigor as the population fit

Pricing structure

Plan sponsors should ask which pricing structure best aligns cost with the population being targeted, the level of control the sponsor has over engagement, and the type of value the vendor claims it will create.

• Per-employee pricing for all eligibles can be appropriate when the solution is meant to be broadly available, and the sponsor wants a simple, predictable budget. The drawback is that the plan may pay for a large eligible population even if only a modest share of members use the service. This model bets heavily on engagement.
• Per-employee pricing for a targeted subset of eligibles can create a better match between fees and expected opportunity, but the sponsor should understand exactly how the target population is defined and how frequently it is refreshed.
• Per-engaged-member pricing may appear to have lower risk because the plan pays only when members interact with the vendor, but this model makes the definition of “engagement” critical. Plan sponsors should understand whether a single inbound call, a completed registration, a coaching session, or a clinically meaningful intervention is what triggers fees and how long those fees last if engagement decreases or does not exist anymore.
• Episode-based or case-rate pricing can make sense for solutions tied to discrete events such as surgery, fertility, or cancer navigation. The key question is whether the fee is being applied to every referred case, only to completed episodes, or only when the vendor's contracted pathway is used.
• Shared savings or contingency-based pricing can be attractive on the surface, but only if the sponsor is comfortable with the baseline, the calculation methodology (is it based on provider discount or theoretical savings?), and the degree to which the vendor controls the outcome it is being paid on.

Plan sponsors should also analyze ancillary costs. More complex vendors may introduce implementation fees, communications support charges, or ongoing file-feed costs. Additionally, the current medical carrier or TPA may impose added fees for coordination with a new vendor.

Prospective savings estimates

Projected savings are often the centerpiece of the sales pitch, but plan sponsors should distinguish between directional modeling and bankable savings. In the sales process, the vendor's estimate may not be based on a true matched-cohort study, but rather on book-of-business experience, benchmark assumptions, or sometimes a more elaborate repricing of the client's historical claims under a set of assumptions about utilization changes. Sponsors should ask critical questions about the estimate’s methodology, what would need to happen for those savings to materialize, and whether they can be independently validated.

• Some vendors propose claims avoidance or reduction in utilization, such as fewer surgeries, lower emergency room use, or lower downstream complication costs.
• Some propose steerage savings, where value depends on successfully moving members to more efficient or lower-cost providers, or curated networks with better pricing or quality controls.
• Some propose improvements in chronic-condition management, adherence, or a decrease in risk factors that are expected to reduce future spend but may not immediately show up as claims savings.
• Some propose softer forms of value such as better access, shorter time to treatment, or an enhanced navigation experience, which may be important but should not be represented as hard-dollar savings unless the methodology supports that conclusion.

Avoided events or services are nearly impossible to independently validate. Where possible and statistically credible (meaning there is enough experience to be considered reasonable on a stand-alone basis), sponsors should ask the vendor to analyze the client's own historical data rather than relying solely on their book-of-business claims. Even then, the sponsor should understand and scrutinize the underlying assumptions. If the model assumes that 60% of eligible members will engage, or that 40% of surgical episodes can be redirected, the sponsor should ask whether those assumptions are reasonable for its own population and what level of sensitivity exists if engagement or redirection is materially lower. Even with good baseline data, actual savings may be difficult to measure accurately given member utilization patterns may shift in unexpected ways.

Certain solutions require an additional layer of review because the provider model itself is a core part of the value proposition. Solutions involving provider contracting, negotiated case rates, bundled payments, or curated referral pathways raise additional questions. Some questions a plan sponsor may have to ask are: How broad is the vendor's provider footprint in the geographies where members live and work? Is steerage voluntary, incentive-driven, or embedded in plan design? For these models, steerage, the network, and contracting help determine whether the projected savings are realistic, whether the incentives for each stakeholder are aligned with the goal, and whether the plan is comfortable with how much direction is applied to a member’s care journey.

Retrospective savings and guarantees

Plan sponsors should agree up front on how success will be measured after implementation. This is when methodologies such as pre/post comparisons, trend-adjusted baselines, or episode-specific studies should be evaluated. The methodology, data source, and timing should be established and included in the contract before launch. Otherwise, the sponsor can end up in a situation where data is not available to evaluate the solutions, or the vendor reports activity, satisfaction scores, and directional ROI before there is a credible framework for determining whether the program is producing value.

Performance guarantees should be evaluated in the same context. Many vendors place some portion of their fees at risk. Sponsors should understand what the guarantees are tied to (e.g., engagement, turnaround times, satisfaction, clinical milestones, or ROI). They should also understand how the result is being measured, what exceptions or exclusions apply, and how much of the vendor’s fees are at risk. A guarantee based on ROI may sound strong, but it becomes less meaningful if the vendor controls the methodology, if the calculation relies on a baseline that is difficult to verify, or if the at-risk amount is small relative to total fees.

Ensure the point solution vendor can work within your benefits program

Even where the economics and impact are attractive, implementation can require additional internal effort. Legal review, privacy review, contracting, eligibility determination, data feeds, carrier coordination, communications planning, member service training, and ongoing issue resolution can all fall on the plan sponsor. Sponsors should be realistic about whether they have the internal capacity not just to launch another vendor but to hold them accountable over time.

Interaction with the existing carrier, TPA, pharmacy benefit manager, and current point solutions deserves particular scrutiny. Many point solutions overlap with existing case management, disease management, care navigation, utilization management, or digital engagement programs. For example, a musculoskeletal vendor may overlap with an existing carrier's physical therapy or care-coordination program, and a navigation vendor may overlap with centers-of-excellence programs. Sponsors should not just ask whether the new vendor is strong on its own, but what programs it may duplicate, displace, or complicate.

Member outreach strategy is part of the operating model. A point solution can fail for reasons that have little to do with clinical design if the membership does not understand who is contacting them, why they are being contacted, or whether the service is endorsed by the plan. Sponsors should understand whether communications will come directly from the vendor or be co-branded with the plan, when outreach will occur, and how the outreach will relate to existing communications. Outreach is especially important for solutions that depend on intervention at the critical moment a member needs care, such as surgery navigation or specialty-care redirection.

Sponsors should also guard against point-solution proliferation. Too many overlapping programs can create confusion in navigating an already difficult healthcare system. Multiple apps, competing outreach campaigns, fragmented reporting, and unclear accountability can make it harder for members to use their benefits. Sometimes the right answer is not another point solution, but a clearer and stronger alignment with the current carrier or TPA, or a more disciplined governance structure around the vendors already in place.

Address compliance, data rights, and contract terms before implementing a health plan point solution

Plan sponsors should be cautious when a vendor's value proposition relies on aggressive assumptions about legal or compliance flexibility. That may include claims about first-dollar coverage compatibility for HDHPs, broad use of member data for outreach, or minimal HIPAA complexity. If the arrangement requires a specific legal interpretation for the economics to work, that issue should be vetted early with counsel rather than treated as a minor implementation detail. The same is true for any arrangement in which vendor outreach, incentives, or design changes may create ERISA, privacy, or discrimination questions.

Data rights and reporting terms also deserve careful attention in the contract. Sponsors should understand what eligibility, claims, and member-level information the vendor will receive; whether the vendor is acting as a Business Associate; what reports they will receive during and after the term; and whether they will have access to the underlying data needed to evaluate performance independently. Sponsors should address audit rights, methodology transparency, data return obligations, and post-termination access before implementation rather than after questions about performance arise.

Finally, sponsors should make sure the contract reflects the decisions made during the evaluation process. For example, eligibility definitions should reflect the target population, and if member outreach and co-branding matter, those expectations should be described rather than left as informal expectations. The contract structure should support the intended operating model.

Steps for adding a point solution: Plan sponsor action items

Define the problem and the target population

• Clarify whether you are trying to address one or more of the following: cost, care quality/access, member experience, or provider steerage.
• Test whether the vendor fits your specific population and current benefits, including prevalence of conditions that the solution supports, claims savings opportunity, workforce characteristics, and realistic communication strategies.

Pressure-test the economics before you buy

• Review all pricing elements, including program fees, implementation, shared-savings, and any other charges.
• Understand the assumptions and methodology of the savings estimates, and how these estimates are sensitive to engagement, steerage, or provider access.
• Evaluate guarantees in the context of methodology, exclusions, and dollars at risk, rather than assuming an ROI guarantee ensures success.

Plan for operations, governance, and member experience

• Assess whether the arrangement will overlap/conflict with current programs.
• Confirm the internal effort required for implementation, ongoing governance, and issue resolution.
• Review member outreach, co-branding, privacy, and data-rights issues before launch.

We’re here to help

Our support is designed to help plan sponsors move beyond a compelling sales story and toward a more disciplined vendor evaluation process.